CHRISTINE CORBETT: Open Payments
NPI 1922285469 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 20 payments from 8 companies in 2025. Trend: 2023 $119 · 2024 $72 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $109 |
| Vifor Pharma, Inc. | 1 | $91 |
| Ardelyx, Inc. | 2 | $59 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Boston Scientific Corporation | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Kerendia, KRYSTEXXA, Veltassa, IBSRELA, BENLYSTA, TAVNEOS, JARDIANCE, EMBOLD Fibered.
Industry payments across NM — which companies pay providers there.
